Global Multiplexed Diagnostics 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03240921

Publication Date:

March 1, 2024

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Multiplexed Diagnostics market size was valued at US$ 1915.7 million in 2023. With growing demand in downstream market, the Multiplexed Diagnostics is forecast to a readjusted size of US$ 3325 million by 2030 with a CAGR of 8.2% during review period.
The research report highlights the growth potential of the global Multiplexed Diagnostics market. Multiplexed Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Multiplexed Diagnostics. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Multiplexed Diagnostics market.
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
Key Features:
The report on Multiplexed Diagnostics market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Multiplexed Diagnostics market. It may include historical data, market segmentation by Type (e.g., Very High Density Multiplexed Assays (Above 10,000-plex), High Density Multiplexed Assays (500 Below plex Below 10,000)), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Multiplexed Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Multiplexed Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Multiplexed Diagnostics industry. This include advancements in Multiplexed Diagnostics technology, Multiplexed Diagnostics new entrants, Multiplexed Diagnostics new investment, and other innovations that are shaping the future of Multiplexed Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Multiplexed Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Multiplexed Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Multiplexed Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Multiplexed Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Multiplexed Diagnostics market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Multiplexed Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Multiplexed Diagnostics market.
麻豆原创 Segmentation:
Multiplexed Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Segmentation by application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Multiplexed Diagnostics 麻豆原创 Size 2019-2030
2.1.2 Multiplexed Diagnostics 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Multiplexed Diagnostics Segment by Type
2.2.1 Very High Density Multiplexed Assays (Above 10,000-plex)
2.2.2 High Density Multiplexed Assays (500 Below plex Below 10,000)
2.2.3 Medium Density Multiplexed Assays (plex Below 500)
2.2.4 Low Density Multiplexed Assays (plex Below 5)
2.2.5 Next Generation Sequencing Assays
2.3 Multiplexed Diagnostics 麻豆原创 Size by Type
2.3.1 Multiplexed Diagnostics 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Multiplexed Diagnostics 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Multiplexed Diagnostics Segment by Application
2.4.1 Academic Research Institutes
2.4.2 Hospital
2.4.3 Pharmaceutical Companies
2.4.4 Clinical Research Organizations
2.4.5 Diagnostic Laboratories
2.5 Multiplexed Diagnostics 麻豆原创 Size by Application
2.5.1 Multiplexed Diagnostics 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Multiplexed Diagnostics 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Multiplexed Diagnostics 麻豆原创 Size by Player
3.1 Multiplexed Diagnostics 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Multiplexed Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Multiplexed Diagnostics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Multiplexed Diagnostics Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Multiplexed Diagnostics by Regions
4.1 Multiplexed Diagnostics 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Multiplexed Diagnostics 麻豆原创 Size Growth (2019-2024)
4.3 APAC Multiplexed Diagnostics 麻豆原创 Size Growth (2019-2024)
4.4 Europe Multiplexed Diagnostics 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Multiplexed Diagnostics 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Multiplexed Diagnostics 麻豆原创 Size by Country (2019-2024)
5.2 Americas Multiplexed Diagnostics 麻豆原创 Size by Type (2019-2024)
5.3 Americas Multiplexed Diagnostics 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multiplexed Diagnostics 麻豆原创 Size by Region (2019-2024)
6.2 APAC Multiplexed Diagnostics 麻豆原创 Size by Type (2019-2024)
6.3 APAC Multiplexed Diagnostics 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Multiplexed Diagnostics by Country (2019-2024)
7.2 Europe Multiplexed Diagnostics 麻豆原创 Size by Type (2019-2024)
7.3 Europe Multiplexed Diagnostics 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Multiplexed Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Multiplexed Diagnostics 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Multiplexed Diagnostics 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Multiplexed Diagnostics 麻豆原创 Forecast
10.1 Global Multiplexed Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Multiplexed Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Multiplexed Diagnostics Forecast
10.1.3 APAC Multiplexed Diagnostics Forecast
10.1.4 Europe Multiplexed Diagnostics Forecast
10.1.5 Middle East & Africa Multiplexed Diagnostics Forecast
10.2 Americas Multiplexed Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Multiplexed Diagnostics 麻豆原创 Forecast
10.2.2 Canada Multiplexed Diagnostics 麻豆原创 Forecast
10.2.3 Mexico Multiplexed Diagnostics 麻豆原创 Forecast
10.2.4 Brazil Multiplexed Diagnostics 麻豆原创 Forecast
10.3 APAC Multiplexed Diagnostics Forecast by Region (2025-2030)
10.3.1 China Multiplexed Diagnostics 麻豆原创 Forecast
10.3.2 Japan Multiplexed Diagnostics 麻豆原创 Forecast
10.3.3 Korea Multiplexed Diagnostics 麻豆原创 Forecast
10.3.4 Southeast Asia Multiplexed Diagnostics 麻豆原创 Forecast
10.3.5 India Multiplexed Diagnostics 麻豆原创 Forecast
10.3.6 Australia Multiplexed Diagnostics 麻豆原创 Forecast
10.4 Europe Multiplexed Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Multiplexed Diagnostics 麻豆原创 Forecast
10.4.2 France Multiplexed Diagnostics 麻豆原创 Forecast
10.4.3 UK Multiplexed Diagnostics 麻豆原创 Forecast
10.4.4 Italy Multiplexed Diagnostics 麻豆原创 Forecast
10.4.5 Russia Multiplexed Diagnostics 麻豆原创 Forecast
10.5 Middle East & Africa Multiplexed Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Multiplexed Diagnostics 麻豆原创 Forecast
10.5.2 South Africa Multiplexed Diagnostics 麻豆原创 Forecast
10.5.3 Israel Multiplexed Diagnostics 麻豆原创 Forecast
10.5.4 Turkey Multiplexed Diagnostics 麻豆原创 Forecast
10.5.5 GCC Countries Multiplexed Diagnostics 麻豆原创 Forecast
10.6 Global Multiplexed Diagnostics Forecast by Type (2025-2030)
10.7 Global Multiplexed Diagnostics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Multiplexed Diagnostics Product Offered
11.1.3 Agilent Technologies Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Information
11.2.2 Bio-Rad Laboratories Multiplexed Diagnostics Product Offered
11.2.3 Bio-Rad Laboratories Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Bio-Rad Laboratories Main Business Overview
11.2.5 Bio-Rad Laboratories Latest Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Information
11.3.2 BioMerieux Multiplexed Diagnostics Product Offered
11.3.3 BioMerieux Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 BioMerieux Main Business Overview
11.3.5 BioMerieux Latest Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Multiplexed Diagnostics Product Offered
11.4.3 F. Hoffmann-La Roche Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 F. Hoffmann-La Roche Main Business Overview
11.4.5 F. Hoffmann-La Roche Latest Developments
11.5 Illumina
11.5.1 Illumina Company Information
11.5.2 Illumina Multiplexed Diagnostics Product Offered
11.5.3 Illumina Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Illumina Main Business Overview
11.5.5 Illumina Latest Developments
11.6 Luminex
11.6.1 Luminex Company Information
11.6.2 Luminex Multiplexed Diagnostics Product Offered
11.6.3 Luminex Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Luminex Main Business Overview
11.6.5 Luminex Latest Developments
11.7 Hologic
11.7.1 Hologic Company Information
11.7.2 Hologic Multiplexed Diagnostics Product Offered
11.7.3 Hologic Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Hologic Main Business Overview
11.7.5 Hologic Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Multiplexed Diagnostics Product Offered
11.8.3 Thermo Fisher Scientific Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Information
11.9.2 Siemens Healthineers Multiplexed Diagnostics Product Offered
11.9.3 Siemens Healthineers Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Siemens Healthineers Main Business Overview
11.9.5 Siemens Healthineers Latest Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Information
11.10.2 Abbott Laboratories Multiplexed Diagnostics Product Offered
11.10.3 Abbott Laboratories Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Abbott Laboratories Main Business Overview
11.10.5 Abbott Laboratories Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.